Latest news
Accelerated KT-621 Trial and Narrower Loss Might Change The Case For Investing In Kymera Therapeutics (KYMR) - finance.yahoo.comfinance.yahoo.com · Thu, 06 Aug 2026 07:15:26 GMTIonis’ top scientist Frank Bennett to retire; Recursion selects its first AI chief - Endpoints NewsEndpoints News · Fri, 31 Jul 2026 07:00:00 GMTThe Escalator: AbbVie, Sarepta Therapeutics, OptimizeRx and more - Medical Marketing and MediaMedical Marketing and Media · Wed, 29 Jul 2026 13:04:21 GMTKymera Therapeutics to Report Q2 2026 Results on Aug 5 - scanx.tradescanx.trade · Tue, 28 Jul 2026 07:00:00 GMTKymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer - The Manila TimesThe Manila Times · Mon, 27 Jul 2026 20:08:08 GMT